Ryan Neinstein
New York, NYNPI 1588929327
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $54,688 of the $61,755 with a category attached, or 88.6%. Solta Medical, A Division Of Bausch Health US, LLC accounts for 75.8% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2023 at $26,923 and has fallen 98.3% since, to $460 in 2025.
Across 195 payments — averaging $316.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Solta Medical, A Division Of Bausch Health US, LLC$47K
- Apyx Medical Corporation$8K
- Merz North America, Inc.$3K
- AbbVie$2K
- Galderma Laboratories, L.p.$783
- Davol Inc.$400
- plus $821 from 11 others
What the payments were for
- Consulting fees$54,68889%
- Food & beverage$7,06811%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Solta Medical, A Division Of Bausch Health US, LLC | 17 | $46,787 |
| Apyx Medical Corporation | 12 | $8,350 |
| Merz North America, Inc. | 23 | $2,844 |
| AbbVie(2 entities) | 75 | $1,770 |
| Galderma Laboratories, L.p. | 36 | $783 |
| Davol Inc. | 6 | $400 |
| Motiva USA, LLC | 7 | $380 |
| Mentor Worldwide LLC | 4 | $76 |
| Pacira Pharmaceuticals Incorporated | 4 | $73 |
| Sientra, Inc. | 2 | $60 |
| Revance Therapeutics, Inc. | 1 | $53 |
| Kowa Pharmaceuticals America, Inc. | 3 | $52 |
| Bard Peripheral Vascular, Inc. | 1 | $46 |
| KCI USA, Inc. | 1 | $25 |
| Coopersurgical, Inc. | 1 | $24 |
| Smith+Nephew | 1 | $18 |
| Tepha Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.